Cargando…
Pharmacological neuroenhancement and the ability to recover from stress – a representative cross-sectional survey among the German population
BACKGROUND: Pharmacological neuroenhancement (PNE) refers to the use of psychoactive substances without doctor’s prescription to enhance cognitive performance or to improve mood. Although some studies have reported that drugs for PNE are also being used to cope with stressful life situations, nothin...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198480/ https://www.ncbi.nlm.nih.gov/pubmed/30348181 http://dx.doi.org/10.1186/s13011-018-0174-1 |
_version_ | 1783364972863029248 |
---|---|
author | Bagusat, Christiana Kunzler, Angela Schlecht, Jennifer Franke, Andreas G. Chmitorz, Andrea Lieb, Klaus |
author_facet | Bagusat, Christiana Kunzler, Angela Schlecht, Jennifer Franke, Andreas G. Chmitorz, Andrea Lieb, Klaus |
author_sort | Bagusat, Christiana |
collection | PubMed |
description | BACKGROUND: Pharmacological neuroenhancement (PNE) refers to the use of psychoactive substances without doctor’s prescription to enhance cognitive performance or to improve mood. Although some studies have reported that drugs for PNE are also being used to cope with stressful life situations, nothing is known about the relationship of PNE and resilience, i.e. the ability to recover from stress. This study aimed at investigating the relationship of PNE and resilience in the first representative population sample. METHODS: A cross-sectional survey in a representative sample of 1128 adults (age ≥ 18 yrs.) living in Germany was conducted. The use of PNE and related attitudes, perceptions and behaviours were assessed by structured interviews and self-report questionnaires. Stepwise logistic regression with backward elimination was conducted to identify potential risk factors for PNE use. RESULTS: Lifetime prevalence for the use of stimulating prescription drugs without medical indication was 4.3%, 10.2% for stimulating illicit drugs, 20.3% for mood modulating prescription drugs, and 23.4% for cannabis. Coping with stressful situations was more frequently reported as underlying motive for using stimulant or mood modulating prescription drugs than stimulating illicit drugs or cannabis. The individual perceived stress increased the risk of using stimulating prescription drugs (OR: 2.86; 95% Cl: 1.49–5.46) and the individual ability to recover from stress decreased the risk of using any substance for PNE and especially mood modulating prescription drugs (OR: .62; 95% Cl: .47–.81). CONCLUSIONS: The non-medical use of prescription drugs for PNE appears to be more prevalent in subjects who are less resilient to stress. Tailored resilience interventions that improve the ability to adapt to and recover from stressors may prevent the use of prescription medication for PNE. Further research should disentangle the association between psychological resilience and PNE as well as examine the efficacy of resilience interventions in the prevention of PNE. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13011-018-0174-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6198480 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-61984802018-10-31 Pharmacological neuroenhancement and the ability to recover from stress – a representative cross-sectional survey among the German population Bagusat, Christiana Kunzler, Angela Schlecht, Jennifer Franke, Andreas G. Chmitorz, Andrea Lieb, Klaus Subst Abuse Treat Prev Policy Research BACKGROUND: Pharmacological neuroenhancement (PNE) refers to the use of psychoactive substances without doctor’s prescription to enhance cognitive performance or to improve mood. Although some studies have reported that drugs for PNE are also being used to cope with stressful life situations, nothing is known about the relationship of PNE and resilience, i.e. the ability to recover from stress. This study aimed at investigating the relationship of PNE and resilience in the first representative population sample. METHODS: A cross-sectional survey in a representative sample of 1128 adults (age ≥ 18 yrs.) living in Germany was conducted. The use of PNE and related attitudes, perceptions and behaviours were assessed by structured interviews and self-report questionnaires. Stepwise logistic regression with backward elimination was conducted to identify potential risk factors for PNE use. RESULTS: Lifetime prevalence for the use of stimulating prescription drugs without medical indication was 4.3%, 10.2% for stimulating illicit drugs, 20.3% for mood modulating prescription drugs, and 23.4% for cannabis. Coping with stressful situations was more frequently reported as underlying motive for using stimulant or mood modulating prescription drugs than stimulating illicit drugs or cannabis. The individual perceived stress increased the risk of using stimulating prescription drugs (OR: 2.86; 95% Cl: 1.49–5.46) and the individual ability to recover from stress decreased the risk of using any substance for PNE and especially mood modulating prescription drugs (OR: .62; 95% Cl: .47–.81). CONCLUSIONS: The non-medical use of prescription drugs for PNE appears to be more prevalent in subjects who are less resilient to stress. Tailored resilience interventions that improve the ability to adapt to and recover from stressors may prevent the use of prescription medication for PNE. Further research should disentangle the association between psychological resilience and PNE as well as examine the efficacy of resilience interventions in the prevention of PNE. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13011-018-0174-1) contains supplementary material, which is available to authorized users. BioMed Central 2018-10-22 /pmc/articles/PMC6198480/ /pubmed/30348181 http://dx.doi.org/10.1186/s13011-018-0174-1 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Bagusat, Christiana Kunzler, Angela Schlecht, Jennifer Franke, Andreas G. Chmitorz, Andrea Lieb, Klaus Pharmacological neuroenhancement and the ability to recover from stress – a representative cross-sectional survey among the German population |
title | Pharmacological neuroenhancement and the ability to recover from stress – a representative cross-sectional survey among the German population |
title_full | Pharmacological neuroenhancement and the ability to recover from stress – a representative cross-sectional survey among the German population |
title_fullStr | Pharmacological neuroenhancement and the ability to recover from stress – a representative cross-sectional survey among the German population |
title_full_unstemmed | Pharmacological neuroenhancement and the ability to recover from stress – a representative cross-sectional survey among the German population |
title_short | Pharmacological neuroenhancement and the ability to recover from stress – a representative cross-sectional survey among the German population |
title_sort | pharmacological neuroenhancement and the ability to recover from stress – a representative cross-sectional survey among the german population |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198480/ https://www.ncbi.nlm.nih.gov/pubmed/30348181 http://dx.doi.org/10.1186/s13011-018-0174-1 |
work_keys_str_mv | AT bagusatchristiana pharmacologicalneuroenhancementandtheabilitytorecoverfromstressarepresentativecrosssectionalsurveyamongthegermanpopulation AT kunzlerangela pharmacologicalneuroenhancementandtheabilitytorecoverfromstressarepresentativecrosssectionalsurveyamongthegermanpopulation AT schlechtjennifer pharmacologicalneuroenhancementandtheabilitytorecoverfromstressarepresentativecrosssectionalsurveyamongthegermanpopulation AT frankeandreasg pharmacologicalneuroenhancementandtheabilitytorecoverfromstressarepresentativecrosssectionalsurveyamongthegermanpopulation AT chmitorzandrea pharmacologicalneuroenhancementandtheabilitytorecoverfromstressarepresentativecrosssectionalsurveyamongthegermanpopulation AT liebklaus pharmacologicalneuroenhancementandtheabilitytorecoverfromstressarepresentativecrosssectionalsurveyamongthegermanpopulation |